Page last updated: 2024-10-30

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Thyroid Cancer, Anaplastic

2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Thyroid Cancer, Anaplastic in 2 studies

2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lv, J1
Liu, C1
Chen, FK1
Feng, ZP1
Jia, L1
Liu, PJ1
Yang, ZX1
Hou, F1
Deng, ZY1
Williamson, AJ1
Doscas, ME1
Ye, J1
Heiden, KB1
Xing, M1
Li, Y1
Prinz, RA1
Xu, X1

Other Studies

2 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Thyroid Cancer, Anaplastic

ArticleYear
M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
    Molecular medicine reports, 2021, Volume: 24, Issue:2

    Topics: Adult; Aged; Antibodies, Neutralizing; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Cell

2021
The sonic hedgehog signaling pathway stimulates anaplastic thyroid cancer cell motility and invasiveness by activating Akt and c-Met.
    Oncotarget, 2016, Mar-01, Volume: 7, Issue:9

    Topics: Cadherins; Cell Line, Tumor; Cell Movement; Chromones; Enzyme Activation; Epithelial-Mesenchymal Tra

2016